logo
Urgent fish recall issued over botulism concerns

Urgent fish recall issued over botulism concerns

Yahooa day ago

Fish sold in multiple U.S. states have been urgently recalled because they may have been contaminated with Clostridium botulinum, a bacterium that can cause illness or death.
P. East Trading Corp. is recalling its Salted Smoked Split Herring, according to a press release shared by the U.S. Food and Drug Administration (FDA) on Tuesday.
The product is five inches in length and uneviscerated, meaning they had not had its internal organs removed. According to the FDA, the recalled fish may contain Clostridium botulinum spores that cause botulism, 'as they are more likely to be concentrated in the viscera than any other portion of the fish.'
Botulism is a rare but serious condition caused by a toxin that attacks the body's nerves. Symptoms include general weakness, dizziness, double-vision, trouble with speaking or swallowing, difficulty in breathing, abdominal distension, and constipation.
The recall came after the Salted Smoked Split Herring was sampled by a New York State Department of Agriculture and Markets Food Inspector. A subsequent analysis of the product confirmed that the 'herring was not properly eviscerated prior to processing.'
There have been no reported illnesses so far.
The recalled fish was sold at retail locations in Connecticut, New Jersey, and New York. It was sold in 18-pound wooden boxes with the container code Lot 1 PRC5073.
However, the FDA noted that the product could have been repacked by retail store workers in 'deli-style or other retail packaging.' A specific list of the stores that received and potentially sold the herring can be found here.
Consumers are urged not to eat the recalled herring. Instead, they should return the product to the place of purchase for a full refund.
This isn't the only product that's been recalled due to a risk of botulinum. In April, Walker's Wine Juice recalled its pumpkin juice, sold in 12 states, because it may have contained the potentially fatal form of food poisoning.
The recall was issued after the New York State Department of Agriculture and Markets Food Inspectors discovered the juice's pH was 'too high to be processed per Walker's 'hot fill' schedule process.'
The recall applied to all lots of Walker's Wine Juice's 2.5-gallon bag in a box and 5-gallon hot pack labeled 'pumpkin' in addition to their 30-, 60-, and 275-gallon bulk containers also labeled 'pumpkin.'
The last two years have also seen an alarming and unexplained rise in recalls. In 2024, approximately 300 food recalls were issued, with those recalls being linked to nearly 1,400 illnesses, a Public Interest Research Group report revealed.
Out of the 1,400 illnesses, 487 people became sick enough to require hospitalization, and 19 people died. While those numbers are still low when weighed against the entire U.S. population, they are also double the number of hospitalizations and deaths from food-borne illnesses in 2023.
In May, cucumbers sold across the country were recalled after people in 15 states reported getting ill from salmonella. Florida-based Bedner Growers, Inc. recalled the vegetables distributed by Fresh Start Produce Sales, Inc. from April 29 to May 19.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA OKs New Next-Gen Pill for Rare Lung Cancer
FDA OKs New Next-Gen Pill for Rare Lung Cancer

WebMD

timean hour ago

  • WebMD

FDA OKs New Next-Gen Pill for Rare Lung Cancer

approved a first-of-its-kind oral pill to treat a rare type of advanced lung cancer that often spreads to the brain. The new drug, known as taletrectinib but sold as Ibtrozi, is meant for adults with non-small-cell lung cancer (NSCLC) that has spread or worsened and is linked to a faulty ROS1 gene. This targeted therapy offers new hope to about 3,000 people in the U.S. and over 1 million globally who are diagnosed each year with advanced ROS1-positive NSCLC. NSCLC is the most common form of lung cancer – a leading cause of cancer-related deaths. About 2% of advanced cases are ROS1-positive, which grow faster and are harder to treat. Most patients are diagnosed in their 50s, often without a history of smoking. The cancer often spreads to the brain, seen in 35% at diagnosis and nearly 50% after treatment. This makes treatment especially challenging and highlights the need for better options. The FDA's decision was based on two clinical studies of people with ROS1-positive NSCLC. One trial involved 113 people who had previously been treated with a drug similar to Ibtrozi, while the other included 157 who had not. About 85% to 90% of those new to treatment responded to Ibtrozi, and at least 63% continued to see benefits for over a year. Among those previously treated, about 52% to 62% improved, with most (up to 83%) continuing to respond for at least six months. Ibtrozi also helped shrink brain tumors in 73% of people who were new to similar treatments, and in 63% of those who had tried one before, according to a news release by Nuvation Bio, the drug's maker. "Ibtrozi's durability of response and ability to effectively penetrate the brain, coupled with a well-characterized and manageable safety profile, further addresses these critical needs for patients," said Nathan Pennell, MD, PhD, a professor of medicine at the Cleveland Clinic and an investigator of the clinical trials. Ibtrozi belongs to a class of medicines called tyrosine kinase inhibitors (TKIs). It blocks the faulty ROS1 protein, helping slow cancer growth and spread. Ibtrozi is designed to reach the brain and keep the disease under control for longer. The FDA recommends 600 mg oral Ibtrozi pills once a day on an empty stomach, with no food two hours before or after taking it. Treatment continues until the cancer worsens or side effects become too serious. The most common side effects include things like nausea, diarrhea, tiredness, and dizziness. The FDA also warns about more serious risks, like liver and lung problems, heart rhythm issues, muscle pain, and possible harm to an unborn baby. People who use the drug should tell their doctor about all medications they're taking, including over-the-counter ones – especially anything for acid reflux. Women are advised not to breastfeed during treatment and for three weeks afterward. It's also important to protect your skin from the sun while taking the drug and for at least five days after stopping it.

Breyers ice cream recalls this popular flavor due to mislabeling, allergy concern
Breyers ice cream recalls this popular flavor due to mislabeling, allergy concern

Yahoo

time2 hours ago

  • Yahoo

Breyers ice cream recalls this popular flavor due to mislabeling, allergy concern

**Related video above: Recalls: Should you be concerned? (WJW) — With ice cream season heating up, yet another company is asking you to check your freezer for recalled treats. Unilever is recalling nearly 7,000 cartons of Breyers Chocolate Truffle Ice Cream, according to the U.S. Food and Drug Administration. The June 2 recall took place after the company said the product was mislabeled and there were undeclared allergens. Find out more about recalls and safety alerts right here The move comes after Turkeyfoot Creek Creamery in Ohio recently recalled eight of its flavors and then also Wells Dairy recalled 18,000 containers of ice cream and frozen yogurt due to potential for hard plastic pieces inside. The people at Breyers reportedly realized some containers of Chocolate Truffle Ice Cream were filled up with Rocky Road topped with a Rocky Road lid. Rocky Road, of course, has almonds, which could be harmful to those with a nut allergy. The FDA said the lid did say almonds were an ingredient. If your 1.5-quart carton of Breyers ice cream has the UPC 077567457288, it could be affected. The FDA said the ice cream was sent to 'distribution centers and retail locations across the U.S.' This recall was categorized as a Class II by the FDA, meaning: 'a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.' 'Water-resistant' spider in NE Ohio eats tadpoles, frogs, and even small fish 'People with an almond allergy should not consume the product due to risk of serious or life-threatening allergic reaction,' the company said in a statement to People. 'The safety and quality of our products is our top priority. For more information, consumers can visit or call 1-800-931-2826.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trump's former surgeon general rips RFK Jr.'s purge of vaccine board
Trump's former surgeon general rips RFK Jr.'s purge of vaccine board

Yahoo

time2 hours ago

  • Yahoo

Trump's former surgeon general rips RFK Jr.'s purge of vaccine board

President Trump's former surgeon general blasted Health and Human Services Secretary Robert F. Kennedy Jr.'s decision to fire the entirety of a federal advisory committee on vaccine guidance, saying the move jeopardizes public health and threatens public trust in health institutions. In an op-ed published by Time, former Surgeon General Jerome Adams wrote that Kennedy's recent actions cast doubt over his pledge that, 'We won't take away anyone's vaccines.' He pointed to the Food and Drug Administration's (FDA) new framework limiting access to COVID-19 vaccines; the Centers for Disease Control and Prevention (CDC) no longer recommending the shot for children and pregnant women; and the removal of members on the CDC's Advisory Committee on Immunization Practices (ACIP). 'These actions collectively restrict access to a vital tool for saving lives and undermine confidence in our health systems,' said Adams, who served in the Trump administration from 2017 to 2021. 'The major flaw in the new vaccine framework is its narrow assessment of risk. Although the immediate dangers of COVID-19 have lessened, it remains a leading cause of death and hospitalization, claiming nearly 50,000 lives in the U.S. in 2024 — more than breast cancer or car accidents,' he added. Kennedy announced Wednesday eight new members of the ACIP to replace the 17 that he had fired. Among the new members were noted spreaders of COVID-19 misinformation. As Endpoints News reported, two of the new picks were previously paid expert witnesses for plaintiffs in a lawsuit against Merck over its HPV and MMR vaccines. Kennedy had financial interests in the HPV vaccine lawsuit before divesting upon being confirmed. In his Thursday op-ed, Adams lamented that seniors and pregnant mothers are at a higher risk of severe COVID-19 outcomes, and the dismissal of the ACIP members only 'amplifies these concerns.' 'ACIP has been a trusted, science-driven body that ensures vaccines are safe and effective, saving countless lives through its transparent recommendations. Its members, rigorously vetted for expertise and conflicts of interest, provide independent guidance critical to public health,' he wrote. 'Removing them without clear evidence of misconduct risks replacing qualified scientists with less experienced voices.' In social media posts following his op-ed, Adams insinuated perjury had taken place, reposting epidemiologist and health economist Eric Feigl-Ding who said Kennedy's promises of not taking away vaccines were 'lies, damn lies.' 'No matter your stance on vaccines, or FDA, or CDC, reasonable and patriotic people should be able to agree that perjury (or even the appearance of intent to deceive Congress) is not an appropriate means to justify a desired end,' Adams said in the post on social platform X. Adams has shared criticisms, some veiled, of the Trump administration's actions and picks for key health positions in recent weeks. After Trump announced Casey Means as his new nominee for surgeon general, Adams took to social media to highlight Means's lack of credentials in comparison to prior surgeon generals such as himself. Writing on X earlier this month, Adams said, 'I do not know and have nothing against Dr. Means – but I feel strongly that the person who is leading America's Public Health Service should be held to the same standard as the people he or she is leading.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store